Tumor hepatitis B virus RNA identifies a clinically and molecularly distinct subset of hepatocellular carcinoma

por Lim, Huat Chye, Gordan, John D.
Publicado 2021

Overexpression-mediated activation of MET in the Golgi promotes HER3/ERBB3 phosphorylation

por Frazier, Nicole Michael, Brand, Toni, Gordan, John D., Grandis, Jennifer, Jura, Natalia
Publicado 2018

ADAP–SLP-76 Binding Differentially Regulates Supramolecular Activation Cluster (SMAC) Formation Relative to T Cell–APC Conjugation

por Wang, Hongyan, McCann, Fiona E., Gordan, John D., Wu, Xiang, Raab, Monika, Malik, Talat H., Davis, Daniel M., Rudd, Christopher E.
Publicado 2004

Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1

por Melnyk, James E., Steri, Veronica, Nguyen, Hao G., Hwang, Y. Christina, Gordan, John D., Hann, Byron, Feng, Felix Y., Shokat, Kevan M.
Publicado 2022

Erratum

por Wang, Hongyan, McCann, Fiona E., Gordan, John D., Wu, Xiang, Moon, Eun-Yi, Raab, Monika, Malik, Talat H., Davis, Daniel M., Rudd, Christopher E.
Publicado 2005

Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice

por Wang, Jingxiao, Dong, Mingjie, Xu, Zhong, Song, Xinhua, Zhang, Shanshan, Qiao, Yu, Che, Li, Gordan, John, Hu, Kaiwen, Liu, Yan, Calvisi, Diego F., Chen, Xin
Publicado 2018

Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish

por Evason, Kimberley J., Francisco, Macrina T., Juric, Vladislava, Balakrishnan, Sanjeev, Lopez Pazmino, Maria del Pilar, Gordan, John D., Kakar, Sanjay, Spitsbergen, Jan, Goga, Andrei, Stainier, Didier Y. R.
Publicado 2015

Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer

por Donnella, Hayley J, Webber, James T, Levin, Rebecca S, Camarda, Roman, Momcilovic, Olga, Bayani, Nora, Shah, Khyati N, Korkola, James, Shokat, Kevan M, Goga, Andrei, Gordan, John D, Bandyopadhyay, Sourav
Publicado 2018

Sampling to capture single-cell heterogeneity

por Rajaram, Satwik, Heinrich, Louise E., Gordan, John D., Avva, Jayant, Bonness, Kathy M., Witkiewicz, Agnieszka K., Malter, James S., Atreya, Chloe E., Warren, Robert S., Wu, Lani F., Altschuler, Steven J.
Publicado 2017

Road map for fibrolamellar carcinoma: progress and goals of a diversified approach

por Kastenhuber, Edward R, Craig, John, Ramsey, Jon, Sullivan, Kevin M, Sage, Julien, de Oliveira, Sofia, Riehle, Kimberly J, Scott, John D, Gordan, John D, Bardeesy, Nabeel, Abou-Alfa, Ghassan K
Publicado 2019

MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment

por Wang, Pan, Song, Xinhua, Utpatel, Kirsten, Shang, Runze, Yang, Yoon Mee, Xu, Meng, Zhang, Jie, Che, Li, Gordan, John, Cigliano, Antonio, Seki, Ekihiro, Evert, Matthias, Calvisi, Diego F., Hu, Xiaosong, Chen, Xin
Publicado 2019

Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma

por Wright, Tricia M, Brannon, A Rose, Gordan, John D, Mikels, Amanda J, Mitchell, Cicely, Chen, Shufen, Espinosa, Inigo, van de Rijn, Matt, Pruthi, Raj, Wallen, Eric, Edwards, Lloyd, Nusse, Roel, Rathmell, W Kimryn
Publicado 2009

Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model

por Dong, Mingjie, Liu, Xianqiong, Evert, Katja, Utpatel, Kirsten, Peters, Michele, Zhang, Shanshan, Xu, Zhong, Che, Li, Cigliano, Antonio, Ribback, Silvia, Dombrowski, Frank, Cossu, Antonio, Gordan, John, Calvisi, Diego F., Evert, Matthias, Liu, Yan, Chen, Xin
Publicado 2018

Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data

por Zack, Travis, Losert, Kurt P., Maisel, Samantha M., Wild, Jennifer, Yaqubie, Amin, Herman, Michael, Knox, Jennifer J., Mayer, Robert J., Venook, Alan P., Butte, Atul, O’Neill, Allison F., Abou-Alfa, Ghassan K., Gordan, John D.
Publicado 2023

A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS

por McMahon, Mary, Contreras, Adrian, Holm, Mikael, Uechi, Tamayo, Forester, Craig M, Pang, Xiaming, Jackson, Cody, Calvert, Meredith E, Chen, Bin, Quigley, David A, Luk, John M, Kelley, R Kate, Gordan, John D, Gill, Ryan M, Blanchard, Scott C, Ruggero, Davide
Publicado 2019

Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms

por Chan, Gary KL, Maisel, Samantha, Hwang, Yeonjoo C, Pascual, Bryan C, Wolber, Rebecca RB, Vu, Phuong, Patra, Krushna C, Bouhaddou, Mehdi, Kenerson, Heidi L, Lim, Huat C, Long, Donald, Yeung, Raymond S, Sethupathy, Praveen, Swaney, Danielle L, Krogan, Nevan J, Turnham, Rigney E, Riehle, Kimberly J, Scott, John D, Bardeesy, Nabeel, Gordan, John D
Publicado 2023